In a ccRCC mouse xenograft model, HIF-2α overexpression was associated with increased tumor growth, whereas inhibiting HIF-2α through RNA interference reduced tumor progression, highlighting HIF-2α as a potential therapeutic target [205]. This evidence concerns the gene EPAS1 and nonpapillary renal cell carcinoma.